The impact of immune markers on thymectomy prognosis in thymoma-myasthenia gravis
Complement C3 level is a crucial predictor for long-term remission in thymoma-associated MG post-thymectomy. Patients with lower C3 levels are more likely to experience MG symptom progression post-surgery compared to those with normal levels, indicating its potential as a key prognostic marker.
Authors
- Yufang Shi (ORCID: https://orcid.org/0000-0001-8964-319X)
- Yuan Chen (ORCID: https://orcid.org/0000-0001-6467-4088)
- Yongqiang Chen (ORCID: https://orcid.org/0000-0002-7961-2485)
- Zirong Wang (ORCID: https://orcid.org/0009-0006-1385-2693)
- Yang Shi
- Hao Wang (ORCID: https://orcid.org/0009-0008-4494-6793)
Institutions
- Tianjin Medical University General Hospital (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/jtd-24-824
- Citations
- 5
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 1.85